Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
330
-
Total 13F shares, excl. options
-
54.6M
-
Shares change
-
-1.67M
-
Total reported value, excl. options
-
$7.12B
-
Value change
-
-$230M
-
Put/Call ratio
-
1.76
-
Number of buys
-
165
-
Number of sells
-
-166
-
Price
-
$130.55
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2016
410 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q1 2016.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 330 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.6M shares
.
Largest 10 shareholders include PUTNAM INVESTMENTS LLC (10.3M shares), FMR LLC (8.92M shares), VANGUARD GROUP INC (4.21M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.04M shares), FIL Ltd (1.8M shares), BlackRock Fund Advisors (1.53M shares), BlackRock Institutional Trust Company, N.A. (1.47M shares), STATE STREET CORP (1.33M shares), Bank of New York Mellon Corp (1.18M shares), and JANUS CAPITAL MANAGEMENT LLC (1.17M shares).
This table shows the top 330 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.